(Nasdaq: IMNM), a biotechnology company committed to developing first-in-class and best-in-class targeted cancer therapies, today announced the submission of a New Drug Application (NDA) to the U.S.

BUENOS AIRES, ARGENTINA / ACCESS Newswire / April 28, 2026 / Loma Negra (NYSE:LOMA)(BYMA:LOMA) ("Loma Negra" or the "Company" ...